REGISTERED NUMBER: |
XPAED LIMITED |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 AUGUST 2023 |
REGISTERED NUMBER: |
XPAED LIMITED |
UNAUDITED FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 AUGUST 2023 |
XPAED LIMITED (REGISTERED NUMBER: 12134401) |
CONTENTS OF THE FINANCIAL STATEMENTS |
FOR THE YEAR ENDED 31 AUGUST 2023 |
Page |
Balance Sheet | 1 |
XPAED LIMITED (REGISTERED NUMBER: 12134401) |
BALANCE SHEET |
31 AUGUST 2023 |
31.8.23 | 31.8.22 |
£ | £ |
CURRENT ASSETS |
CREDITORS |
Amounts falling due within one year | ( |
) | ( |
) |
NET CURRENT LIABILITIES | ( |
) | ( |
) |
TOTAL ASSETS LESS CURRENT LIABILITIES |
( |
) |
( |
) |
CREDITORS |
Amounts falling due after more than one year |
NET LIABILITIES | ( |
) | ( |
) |
CAPITAL AND RESERVES | ( |
) | ( |
) |
NOTES TO THE FINANCIAL STATEMENTS |
1. | STATUTORY INFORMATION |
Xpaed Limited is a |
Registered number: |
Registered office: |
2. | AVERAGE NUMBER OF EMPLOYEES |
The average number of employees during the year was |
3. | TRANSACTIONS WITH DIRECTORS |
As at 31 August 2023 the company owed the director £68,482 (2022: £108,482) which is included within the creditors amounts falling due within one year. |
The balance is interest free and repayable on demand. |
XPAED LIMITED (REGISTERED NUMBER: 12134401) |
BALANCE SHEET - continued |
31 AUGUST 2023 |
NOTES TO THE FINANCIAL STATEMENTS |
4. | CONTINGENT LIABILITIES |
During the prior periods, Xpaed Limited received grant funding in relation to clinical trials being undertaken. The purpose of the grant is to support ongoing eligible project expenditure. Should any conditions of the grant be contravened or unspent, then the grant could become repayable to the funder. |
The directors acknowledge their responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the Board of Directors and authorised for issue on |